Worldwide Chronic Heart Failure Therapeutics Pipeline Report 2016 - Review of 17 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Chronic Heart Failure - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Chronic Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Heart Failure and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Chronic Heart Failure Overview
  3. Therapeutics Development
  4. Pipeline Products for Chronic Heart Failure - Overview
  5. Pipeline Products for Chronic Heart Failure - Comparative Analysis
  6. Chronic Heart Failure - Therapeutics under Development by Companies
  7. Chronic Heart Failure - Therapeutics under Investigation by Universities/Institutes
  8. Chronic Heart Failure Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Chronic Heart Failure - Products under Development by Companies
  13. Chronic Heart Failure - Products under Investigation by Universities/Institutes
  14. Chronic Heart Failure - Companies Involved in Therapeutics Development
  • Amgen Inc.
  • AnGes MG, Inc.
  • Bayer AG
  • Capricor Therapeutics, Inc.
  • Celyad SA
  • Juventas Therapeutics, Inc.
  • Laboratoires Pierre Fabre SA
  • Les Laboratoires Servier SAS
  • Mast Therapeutics, Inc.
  • Mesoblast Limited
  • Novartis AG
  • Pfizer Inc.
  • PhaseBio Pharmaceuticals, Inc.
  • Sanofi
  • Stemedica Cell Technologies, Inc.
  • Vichem Chemie Research Ltd.
  • Zensun (Shanghai) Sci & Tech Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/p8hlrk/chronic_heart

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular Drugs